NTRB NutriBand Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Nasdaq · SEC CIK 1676047 · Fiscal year ends 01/31
Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-37.3%
TTM net income YoY32.2%
TTM EPS YoY83.0%
Revenue 3-yr CAGR-10.8%
Net income 3-yr CAGR—
Margins
Gross margin33.1%
Operating margin-435.6%
Net margin-430.4%
FCF margin—
EBITDA margin-426.5%
Returns
ROE-100.7%
ROA-84.6%
ROIC (approx.)-326.9%
Asset turnover0.20x
Leverage & solvency
Liabilities / assets15.3%
Debt / equity0.00x
Current ratio4.21x
Interest coverage-339.35x
Cash quality & payout
Operating cash flow / net income0.52x
Accruals ratio-40.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-31 | FY20252025-01-31 | FY20242024-01-31 | FY20232023-01-31 | FY20222022-01-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $2.04M | $2.14M | $2.09M | $2.08M | $1.42M |
| Cost of revenue | $1.47M | $1.40M | $1.22M | $1.33M | $917,844 |
| Gross profit | $566,308 | $743,317 | $862,105 | $750,404 | $554,310 |
| R&D expense | $1.89M | $3.12M | $1.96M | $982,227 | $411,383 |
| SG&A expense | $6.99M | $4.31M | $3.77M | $3.92M | $4.02M |
| Operating income | -$8.32M | -$10.28M | -$4.87M | -$4.48M | -$6.11M |
| Interest expense | $22,535 | $21,407 | $75,815 | $8,289 | $118,421 |
| Pretax income | -$8.23M | -$10.48M | -$5.49M | -$4.48M | -$6.18M |
| Net income | -$8.23M | -$10.48M | -$5.49M | -$4.48M | -$6.18M |
| EBITDA | -$8.12M | -$10.00M | -$4.58M | -$4.15M | -$5.80M |
| EPS (basic) | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
| EPS (diluted) | -2.58 | -0.99 | -0.69 | -0.53 | -0.80 |
| Weighted avg. shares (diluted) | 11.64M | 10.61M | 7.95M | 8.46M | 7.93M |
| Banking | |||||
| Loans, net | — | — | — | — | $121,544 |
| Deposits | — | — | — | $250,000 | $250,000 |
| Balance sheet | |||||
| Cash & equivalents | $4.57M | $4.31M | $118,675 | $1.99M | $4.89M |
| Receivables | $118,404 | $73,847 | $148,649 | $113,045 | $71,380 |
| Inventory | $117,987 | $212,041 | $168,605 | $229,335 | $131,648 |
| Current assets | $4.99M | $4.79M | $1.02M | $2.69M | $5.47M |
| PP&E, net | $567,255 | $695,063 | $774,924 | $897,735 | $979,297 |
| Goodwill | $1.72M | $1.72M | $5.02M | $5.02M | $5.35M |
| Intangibles | $200,427 | $261,092 | $667,280 | $780,430 | $926,913 |
| Total assets | $7.55M | $7.47M | $7.52M | $9.46M | $12.74M |
| Current liabilities | $784,281 | $982,845 | $999,093 | $748,613 | $779,256 |
| Short-term debt | — | — | $2.00M | — | — |
| Total liabilities | $868,447 | $1.04M | $1.08M | $883,387 | $880,375 |
| Shareholders' equity | $6.68M | $6.43M | $6.44M | $8.57M | $11.86M |
| Shares outstanding | 12.16M | 11.07M | 8.86M | 7.83M | 9.15M |
| Cash flow statement | |||||
| Operating cash flow | -$5.13M | -$4.63M | -$3.53M | -$2.99M | -$2.81M |
| Capital expenditure | $5,324 | $92,043 | $51,761 | $79,304 | $81,595 |
| Free cash flow | -$5.14M | -$4.72M | -$3.58M | -$3.07M | -$2.89M |
| Investing cash flow | -$5,324 | -$92,043 | -$51,761 | -$79,304 | -$81,595 |
| Financing cash flow | $5.40M | $8.54M | $2.09M | $160,074 | $7.63M |
| Depreciation & amortization | $193,797 | $285,054 | $287,722 | $330,143 | $308,741 |
| Stock-based compensation | $2.63M | $1.41M | $499,856 | $732,130 | $365,000 |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.